Key takeaway: If minimizing tricuspid valve interference is paramount, leadless pacing avoids a transvalvular lead and generally shows lower TR progression. If physiologic pacing/synchrony is critical (e.g., HF, CRT-alternative), LBBAP may be preferred—but technique is essential to reduce leaflet interaction.
Comparative Table: Tricuspid & Clinical Considerations
| Dimension | Leadless Pacemaker | Transvenous LBBAP |
|---|---|---|
| Tricuspid Valve Interaction | No lead crossing the valve → minimal risk of leaflet/chordal impingement. | Lead traverses tricuspid valve → potential leaflet interference, annular tethering, and TR progression. |
| Risk of TR Progression | Generally lower vs. conventional transvenous systems; rare TR progression reported. | New/worsened TR reported, especially with basal septal or annular-adjacent positions. |
| Pacing Physiology | Single-chamber RV support; simpler, but no AV synchrony. | Conduction-system pacing (His/LBB) for more physiologic activation and synchrony. |
| Imaging Needs | Pre-implant TTE; routine TTE follow-up (often stable). | Pre-implant TTE/TEE or CT to map annulus & septum; post-implant echo to verify no leaflet impingement. |
| Device Longevity / Hardware | Pocketless, no lead fracture risk; finite battery, retrieval/re-implant planning. | Standard generator longevity; lifelong lead burden, potential fracture/infection/venous issues. |
| Complications Profile | Lower lead-related issues; rare perforation/embolization. | Lead fracture/infection/occlusion; extraction complexity over time. |
| Best Suited For | Situations prioritizing valve preservation or prior lead-related TR. | Patients needing physiologic pacing (HF, dyssynchrony concerns) with manageable TR risk. |
| Monitoring Strategy | Baseline + annual TTE; monitor for rare TR or device migration. | Baseline 3D echo; repeat at 6–12 months and if symptoms/RV changes occur. |
Imaging & Procedural Checkpoints
- Before LBBAP: 3D TTE/TEE or CT to size the annulus, assess leaflet mobility, and plan a mid-septal—not basal—target away from the annulus/chordae.
- During LBBAP: Consider intracardiac echo or fluoroscopic views that confirm distance from the tricuspid annulus; avoid basal septal positions.
- After LBBAP: Early post-implant echo to exclude leaflet tethering; follow-up TTE to trend TR grade, RV size/function.
- Leadless Pathway: Standard pre-implant TTE; follow-up echo typically stable unless RV remodeling or rare device-related issues emerge.
Decision Matrix (Quick Use)
- Valve protection priority → Prefer Leadless.
- Physiologic activation priority (HF/CRT-alternative) → Consider LBBAP with meticulous technique and structured echo follow-up.
- Pre-existing moderate–severe TR → Avoid introducing new transvalvular leads when possible; evaluate leadless strategy.
- Progressive TR with an existing LBBAP lead → Assess mechanism (functional vs mechanical impingement); consider lead reposition/extraction + leadless if appropriate.
Clinical note: Echo grading (vena contracta, PISA when applicable, hepatic vein flow), RV size/function, and annular dimensions should guide longitudinal decisions.